W
hen it comes to acute ischemic stroke treatment, we have learned from randomized trials regarding intravenous alteplase treatment that time is brain. [1] [2] [3] Studies performed in clinical practice have extended our knowledge regarding the association of time with outcome and provide data that are better applicable to routine clinical practice. [4] [5] [6] Endovascular treatment (EVT) has been proven highly effective in patients with acute ischemic stroke caused by proximal intracranial artery occlusion in the anterior circulation, [7] [8] [9] [10] [11] [12] and therefore this treatment became standard of care in 2015. 13 Before these positive EVT trials, data from several other studies had already suggested that faster reperfusion is associated with better outcomes after EVT. [14] [15] [16] [17] Shorter time from stroke onset to EVT start has been suggested to be one of the important factors in the success of the positive trials. 18 A meta-analysis of data from the first 5 positive trials showed that every hour delay in time from onset to start of EVT resulted in a 3.4% decreased probability of functional independence. For every hour delay in time from onset to successful reperfusion, there was a 5.2% decreased probability of functional independence. 19 These findings may not be fully generalizable to clinical practice because of strict in-and exclusion criteria. Specifically, most trials selected patients on additional imaging criteria, such as Alberta Stroke Program Early Computed Tomography Score (ASPECTS) thresholds, perfusion imaging, and collateral status. [8] [9] [10] [11] Our aim was to assess the association of time from stroke onset to EVT and to successful reperfusion with outcome in current clinical practice.
METHODS
We used data from the MR CLEAN Registry (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in The Netherlands), 20 an ongoing, prospective, observational study in all centers that perform EVT in The Netherlands. Registration started directly after the final randomization in March 2014, in the MR CLEAN trial. The central medical ethics committee of the Erasmus Medical Center Rotterdam, The Netherlands, evaluated the MR CLEAN Registry study protocol and granted permission to carry out the study as a registry (MEC-2014-235) . The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Centers
All 16 intervention centers that participated in the MR CLEAN trial registered their EVT patients. All patients who underwent EVT for acute ischemic stroke in the anterior or posterior circulation in these centers have been registered in the MR CLEAN Registry.
Patients
For the purpose of this analysis, we used the following inclusion criteria: groin puncture within 6.5 hours after stroke onset; age of 18 years and older; treatment in a MR CLEAN trial center; intracranial proximal arterial occlusion in the anterior circulation ( 
Clinical Definitions
The EVT definition is actual artery puncture in the angiography suite in acute ischemic stroke patients. The exact choice of endovascular treatment modality for each patient was left to the discretion of the local interventionists. Stroke onset was defined as the moment of witnessed symptom onset or the moment that the patient was last seen well if the actual onset was unwitnessed. ASPECTS was graded from 0 to 10, with 1 point subtracted from 10 for any evidence of early ischemic changes in each defined region on noncontrast computed tomography. 21 We defined time to start of EVT as the time from stroke onset to arterial puncture. We defined time from onset to successful reperfusion as the time from stroke onset to successful reperfusion in patients in whom an actual
Clinical Perspective
What Is New?
• Time to endovascular treatment for acute ischemic stroke in current clinical practice is strongly associated with functional outcome, and this association might be even stronger than previously suggested in reports on more selected patient populations from randomized, controlled trials.
• Every hour delay in time from stroke onset to endovascular treatment start results in a 5.3% decreased probability of functional independence and a 2.2% increase in mortality.
• Every hour delay from stroke onset to successful reperfusion results in a 7.7% decreased probability of functional independence.
What Are the Clinical Implications?
• These findings emphasize that functional outcome of patients who undergo endovascular treatment can be greatly improved by shortening onset to treatment times.
• Reducing delays in the delivery of endovascular treatment should be a primary objective of all stroke centers that refer or treat patients with acute ischemic stroke.
• Given the clear association of time to treatment with functional outcome, this is an important factor in comparing endovascular treatment studies and cohorts. 
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thrombectomy attempt was performed. Patients were not analyzed for this time window when the extended thrombolysis in cerebral ischemia (eTICI) score was <2A at the end of the intervention, when no target occlusion was seen during intervention, or when the target occlusion was not reached. Successful reperfusion was defined as a score on the eTICI score scale ≥2B.
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Outcome Measures
For the present analysis, the primary outcome was the modified Rankin Scale (mRS) score at 90 days. The mRS is a 7-point scale ranging from 0 (no symptoms) to 6 (death). A score of ≤2 points indicates functional independence. 23 Secondary outcomes were excellent (mRS of 0-1), good (mRS of 0-2), and favorable (mRS of 0-3) functional outcome, mortality, eTICI, and occurrence of symptomatic intracranial hemorrhage. The eTICI scores range from grade 0 (no reperfusion) to grade 3 (complete reperfusion). 22 An independent core laboratory, blinded for clinical outcome, assessed all digital subtraction angiographies. Hemorrhages were evaluated by the complication committee and the imaging core laboratory according to the Heidelberg criteria.
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Statistical Analysis
Baseline characteristics of the study population are tabulated by three subgroups according to onset to treatment time (<150, 151-270, 271-390 minutes), for illustration only. The primary analysis assessed the association of time from stroke onset to EVT as a continuous variable (onset to EVT) and onset to successful reperfusion with functional outcome, by means of ordinal logistic regression. For all analyses, time to EVT odds ratios were expressed per hour increase in time. Secondary analyses assessed the associations of time to EVT with secondary outcomes. Finally, in an exploratory analysis the association of other time intervals with functional outcome were analyzed. Any mRS score of 0 to 5 assessed within 30 days of symptom onset was considered invalid and treated as missing. These values were therefore replaced by mRS scores derived from multiple imputation for regression analyses. For both primary and secondary analyses, unadjusted and adjusted regression analyses were performed. We adjusted for age, sex, National Institutes of Health Stroke Score at baseline, collateral score, and additionally for baseline ASPECTS in the analysis of symptomatic intracranial hemorrhage. Selection of these variables for adjustments was based on evidence from previous studies. The association of time to EVT with functional independence (mRS 0-2) was shown in adjusted margin plots. All statistical analyses were performed with STATA/SE software (version 14.1; StataCorp, Boulder, CO).
RESULTS
Overall, 1488 patients were included in this analysis (Figure 1) . For all patients, an estimate of stroke onset time was available. In 1117 patients (75%) this concerned the actual time of stroke onset and for the other 371 patients (25%) the time last seen well. The time of groin puncture was available for all subjects ( Figure IA in the online-only Data Supplement). In 1280 patients (86%) the target occlusion was actually reached and an attempt to remove the thrombus was made. When no attempt was made to remove the target occlusion this was because the target occlusion was not accessible (80 patients [5%]) or no target occlusion was present (spontaneously dissolved or migrated distally) on digital subtraction angiography (119 patients [8%]) or the intervention was stopped for other reasons (9 patients [1%]). For 1272 of the 1280 (99%) patients in whom removal of the thrombus was attempted, the time of reperfusion or end of the procedure was available, and 1266 patients (98%) had a posteTICI scored by the imaging core laboratory. For 1363 patients the mRS score was not imputed, so multiple imputation for regression analysis was performed in all 125 remaining patients (8%).
Median age was 71 (interquartile range [IQR], 60-80), 794 patients (53%) were male, National Institutes of Health Stroke Score at baseline was 16 (IQR, [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and in 1161 patients (78%) intravenous alteplase was administered before EVT (Table 1) . Successful reperfusion was achieved in 743 (59% of the 1266 patients in whom thrombectomy was attempted and intervention images were available), and in 1 patient the time of reperfusion was missing (Figure IB in the online-only Data Supplement). At 90 days after stroke, 517 of 1363 patients (38%) were independent (mRS 0-2) and mortality occurred in 398 patients (29%). In total 86 (5.8%) of the 1488 patients had a symptomatic intracranial hemorrhage. Table 2, and Table I in the online-only Data Supplement). The probability of functional independence declined from 47.3% at 90 minutes to 21.0% at 390 minutes, resulting in a 5.3% decreased probability of functional independence per hour delay ( Figure 3A ). Time to start of EVT was also significantly associated with mortality, which increased by 2.2% per hour treatment delay ( Figure II in the online-only Data Supplement). We found no association between later start of EVT and successful reperfusion during EVT, nor with symptomatic intracranial hemorrhage occurrence ( Table 2) .
The associations of time from onset to successful reperfusion with functional outcome and complications were similar in the 742 patients with successful reperfusion and available onset to reperfusion time ( Figure 2B , Table 3, and Table II in the online-only Data Supplement). In the ordinal analysis, the association was significant, with an adjusted common odds ratio of 0.79 (95% CI, 0.71-0.88). The probability of functional independence declined from 62.7% at 120 minutes to 24.4% at 420 minutes, resulting in a 7.7% decreased probability of functional independence per hour increase ( Figure 3B ). *In 9 patients the occlusion location was considered to be M2 at the moment the decision for EVT was made, but the imaging core laboratory observed an M3 occlusion. Six patients had a proximal occlusion in anterior cerebral artery (A1/A2). There were 12 patients who underwent EVT without a definitive occlusion on CTA according to the core laboratory †Admission between 5pm and 8am, on weekends, or on a national holiday. Atrial fibrillation, n (%) 58 (19) 189 (22) 80 (24) Myocardial infarction, n (%)
51 (16) 132 (15) 45 (14) Peripheral artery disease, n (%)
27 (9) 83 (10) 25 (8) Ischemic stroke, n (%) 46 (15) 159 (19) 45 (14) Prestroke modified Rankin Scale score, n (%) 
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We also considered the effect of time to reperfusion on functional independence for varying definitions of reperfusion. We found no time association between time and good outcome in in the eTICI 0 and 1 groups. The strongest association with outcome was found in the eTICI 2C and eTICI3 groups (Table III in the online-only Data Supplement). Despite inevitable inaccuracies in assessment of onset time we found strong associations with functional outcome. Moreover, other, perhaps more exact time intervals showed similar and significant associations with outcome (Table IV in the online-only Data Supplement). Additional analysis of the association of time using only witnessed stroke onset, leaving out the patients with unwitnessed onset, shows a similar association of time with outcome: adjusted common odds ratio 0.79 (95% CI, 0.71-0.87).
DISCUSSION
In this study we assessed the association of time with outcome of acute ischemic stroke patients treated with EVT in current clinical practice. Every hour delay from stroke onset to start of EVT resulted in a 5.3% decreased probability of functional independence (mRS 0-2). Every hour that successful reperfusion was delayed resulted in a 7.7% decreased probability of functional independence. Only 2 studies have described outcome of patients who underwent EVT in the current clinical setting, where EVT is standard of care. The first study did not ORIGINAL RESEARCH ARTICLE study the effect of time to EVT on functional outcome. 25 The second was a large multicenter study in 984 patients treated with 1 type of thrombectomy device (Solitaire or Mindframe), which might not adequately represent EVT in the setting of routine clinical practice. 26 When comparing the association of EVT times with functional outcome to the HERMES metaanalysis (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) of previous randomized EVT trials, our results suggest that the association might be even stronger in routine clinical practice. Every hour that EVT was started later resulted in less functional independence at 90 days (5.3% versus 3.4% per hour decline; estimates based on odds ratios in Table 2 ). Also, for every hour that successful reperfusion was achieved later, there was a larger decline of functional independence in our data than in the HERMES dataset (7.7% versus 5.2%). 19 The HERMES data included randomized, controlled trials only, but the association of time to EVT outcome could only be estimated in the arms of the randomized, controlled trials treated with EVT. From the perspective of our research question the designs of HERMES and the MR CLEAN Registry are similar and differences in patient selection seem the most likely explanation for the stronger time association with outcome that we observed in the MR CLEAN Registry. 12 Furthermore, no standard selection on additional imaging was performed and there were no collateral or ASPECTS thresholds. Therefore, the data of the MR CLEAN Registry represents in our view the closest estimation of the true time association with functional outcome in EVT, although patient and time selection in our data cannot be completely excluded.
Our results confirm the following statement in the HERMES meta-analysis regarding time to EVT (statistical analysis plan): "since imaging selection (ASPECTS thresholds, perfusion imaging, and collateral imaging) was used to some degree in many of the enrolled patients, time effects observed in this pooled population are likely less than those that would occur in a population in which no imaging-selection whatsoever was used." 19 In the DEFUSE 2 trial (Diffusion Weighted Imaging Evaluation for Understanding Stroke Evolution Study-3), for example, the association between endovascular reperfusion and improved functional outcomes was not time dependent in patients with a perfusiondiffusion mismatch. 27 This emphasizes that the effect of time to treatment on outcome is diminished in a population in which strict patient selection for EVT has been applied. Additional imaging selection results in a patient population that may be more tolerant to delays in onset to reperfusion. As such, additional imaging selection may play an important role in selecting EVT patients who arrive outside the 6-hour time window or af- For this analyses time was used as a continuous variable and age, sex, baseline National Institutes of Health Stroke Score, and collaterals score were used for adjustments. A, Time from stroke onset to start of endovascular treatment (EVT). There was a 5.3% decreased probability of functional independence per hour delay. B, Time from stroke onset to successful reperfusion. There was a 7.7% decreased probability of functional independence per hour delay. Patients who were treated faster had more favorable characteristics in our study: younger age, less atrial fibrillation, lower prestroke mRS, higher ASPECTS, and less likely to receive general anesthesia. Therefore, it can be hypothesized that the association of faster EVT with better functional outcome is caused by favorable patient prognostic factors. However, as shown in Tables 2 and 3 , adjusting for the most important prognostic factors in EVT resulted in very similar associations of EVT times with outcome. Even when extra factors are added (general anesthesia, prestroke mRS, ASPECTS, atrial fibrillation) the association with functional outcome remains almost identical: adjusted common odds ratio=0.84 (95% CI, 0.78-0.91), thus the observed confounding is negligible in our data. Therefore, we consider it likely that the effect of unobserved confounding will also be of little importance.
We found a significant association between longer time to treatment and increased mortality, in contrast to HERMES. That our study shows a significant difference could be well explained by the larger sample size and the older patient population. EVT workflow in the MR CLEAN Registry was clearly better than during the MR CLEAN trial. The time interval from onset to start of EVT was decreased by 52 minutes, and the time interval from onset to reperfusion was decreased by 80 minutes on average. 30 This improvement was achieved despite the increased number of patients who were transferred from a primary stroke center (55% versus 44% during the MR CLEAN trial). A factor that contributed to the reduced treatment delays was that no randomization was necessary (with the concurring informed consent procedure), which resulted in faster computed tomographyangiography to groin times, after initiation of treatment with intravenous alteplase. Faster onset to EVT times will greatly improve treatment benefit, and it may result in more patients being candidates for EVT. 31 These findings emphasize that functional outcome of patients who undergo EVT can be greatly improved by shortening onset to treatment times. Therefore, reducing delays in the delivery of EVT should be a primary objective of all stroke centers that refer or treat patients with acute ischemic stroke. 32 At last, given the clear association of time to treatment with functional outcome, this is an important factor in comparing EVT studies and cohorts.
This study has several limitations. Generalizability of our results may be limited because these data originate only from Dutch intervention centers. However, our broad entry criteria will enhance the generalizability of our results and conclusions. Secondly, it is unknown which possible candidates with large vessel occlusion were not brought to the angiography suite, so a selection of possible EVT candidates cannot be excluded. However, this is one of the few studies in which patients with poor ASPECTS and collateral status were included and treated, which suggests that patients with a poor prognosis were not systematically excluded from EVT. Moreover, inherent to any registry study, nonregistration of treated patients might be an issue. Because registration of treatment was a prerequisite for reimbursement, we think that underregistration is minimal. Finally, these data were gathered in routine clinical practice. Registries in general are prone to missing and incorrect values. However, all data were verified by our study coordinators, with particular focus on all entered treatment times. This resulted in a near complete and verified dataset available for this analysis (100% of stroke onset and start of EVT times and 99% of reperfusion times). Furthermore, no central outcome adjudication was available for our study, so we relied on local investigators for reporting the functional outcome at 90 days, possibly introducing optimism bias. Optimistic reports from local investigators could have resulted in a larger proportion of patients achieving functional independence. However, outcome assessment was by stroke or research nurses who were not involved in treatment of patients, and was performed according to standard questionnaires.
To conclude, in current clinical practice, every hour delay from acute ischemic stroke onset to start of EVT results in a >5% decreased probability of functional independence (mRS 0-2). Every hour delay of successful reperfusion results in an almost 8% decreased probability of functional independence. This association might even be stronger than previously suggested in reports on more selected patient populations from randomized, controlled trials. Our data further emphasize that functional outcome of EVT patients can be greatly improved by reducing treatment delays.
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